New & Noteworthy!

ACC Rockies Chapter Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit: ACC Rockies Chapter Meeting 2025

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • State of the States 2025: ACC Chapters Advancing CV Care Through Education, Advocacy, and Connection
    In 2025, ACC Chapters across the U.S. demonstrated the power of grassroots leadership in advancing cardiovascular care. Through record-breaking educational meetings, landmark advocacy victories, innovative equity initiatives, and expanded professional development...
  • Eagle’s Eye View: Beta-Blocker vs. Calcium-Channel Blocker in HCM
    In this week’s View, Dr. Eagle looks at the differential effect of bisoprolol versus verapamil in nonobstructive hypertrophic cardiomyopathy (HCM) treatment.
  • JACC: Asia State-of-the-Art Review Spotlights Role of AI in CV Medicine
    With technological advances like artificial intelligence (AI), machine learning and digital health tools moving from concept into clinical practice, a State-of-the-Art Review in JACC: Asia offers a comprehensive look at digital innovation spanning the full spectrum of cardiology from prevention to treatment to research.
  • JACC Spotlight Issue Focuses on CV Statistics in US
    A special JACC spotlight issue supporting the journal’s recent Cardiovascular Statistics 2026 (JACC Stats) report published online earlier this year offers a comprehensive snapshot of cardiovascular health in the U.S. today. The focused issue, which also includes the inaugural report, expands the analysis beyond clinical disease to the broader drivers of cardiovascular health, examining trends […]
  • RENOVATE-COMPLEX-PCI: Benefit With Intravascular Imaging Guidance Maintained at 5 Years
    In the multicenter open-label superiority trial, Joo Myung Lee, MD, MPH, PhD, FACC, et al., randomized 1,639 patients (mean age 66; 20% women) with complex coronary artery lesions across 20 hospitals in South Korea 2:1 to either intravascular imaging-guided PCI (n=1,092) or angiography-guided PCI (n=547). Of the overall cohort, 49% presented with stable ischemic heart […]